Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma

Tumor-infiltrating lymphocytes include tumor-reactive lymphocytes and regulatory T-cells. However, the prognostic value of tumor-infiltrating lymphocytes in oral squamous cell carcinoma (OSCC) remains unclear. We used immunohistochemistry to evaluate the presence of tumor-infiltrating FoxP3⺠T-cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-08, Vol.15 (8), p.e0237465-e0237465
Hauptverfasser: Koike, Kazushige, Dehari, Hironari, Ogi, Kazuhiro, Shimizu, Shota, Nishiyama, Koyo, Sonoda, Tomoko, Sasaki, Takanori, Sasaya, Takashi, Tsuchihashi, Kei, Hasegawa, Tadashi, Torigoe, Toshihiko, Hiratsuka, Hiroyoshi, Miyazaki, Akihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0237465
container_issue 8
container_start_page e0237465
container_title PloS one
container_volume 15
creator Koike, Kazushige
Dehari, Hironari
Ogi, Kazuhiro
Shimizu, Shota
Nishiyama, Koyo
Sonoda, Tomoko
Sasaki, Takanori
Sasaya, Takashi
Tsuchihashi, Kei
Hasegawa, Tadashi
Torigoe, Toshihiko
Hiratsuka, Hiroyoshi
Miyazaki, Akihiro
description Tumor-infiltrating lymphocytes include tumor-reactive lymphocytes and regulatory T-cells. However, the prognostic value of tumor-infiltrating lymphocytes in oral squamous cell carcinoma (OSCC) remains unclear. We used immunohistochemistry to evaluate the presence of tumor-infiltrating FoxP3⺠T-cells and CTLA-4⺠cells in four distinct histological compartments (tumor parenchyma and stroma at the tumor center, and parenchyma and stroma at the invasive front) and assessed the association between the prevalence of these cells and the histopathological status of 137 patients with OSCC. Five-year overall survival, disease-specific survival, and recurrence-free survival were favorable in patients with high numbers of FoxP3⺠T-cells in the parenchyma of the invasive front. Recurrence-free survival and metastasis-free survival were decreased in patients with high numbers of CTLA-4⺠cells in the parenchyma of the invasive front. The presence of FoxP3⺠T-cells in the parenchyma of the invasive front may be a useful prognostic factor. Our results indicate that FoxP3⺠T-cells may exert site-specific anti-tumor effects but may not play an immunosuppressive role in OSCC. In addition, our results suggest that CTLA-4.sup.+ cells suppress the function of FoxP3.sup.+ T-cells and promote anti-tumor immunity in OSCC.
doi_str_mv 10.1371/journal.pone.0237465
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_gale_healthsolutions_A632306451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A632306451</galeid><doaj_id>oai_doaj_org_article_8e353a9de3c242e8ab7829d2bd67e67b</doaj_id><sourcerecordid>A632306451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-94bf09e3d9a0173578b811a640a372bfbbc63c7f515024d84ed808b42c8c9a963</originalsourceid><addsrcrecordid>eNqNk11rFDEUhgdRbK3-A8GAIHqxaybJ5OOmsCxWFxZatHon4Uwms5syM9kmM3X992bdUTrSC8lFwsmT9-S8nJNlL3M8z6nI39_4IXTQzHe-s3NMqGC8eJSd5oqSGSeYPr53PsmexXiDcUEl50-zE0qELIjCp9n3q-A3nY-9M-gOmsEiX6MLv7-iCLoKLa_XixlDdr8LNkbnO-Q6tIPe2a6P6Ifrt8gHaFC8HaD1Q0TGNg0yEIzrfAvPsyc1NNG-GPez7OvFh-vlp9n68uNquVjPDOeqnylW1lhZWinAuaCFkKXMc-AMAxWkrMvScGpEXeQFJqySzFYSy5IRI40CxelZ9uqou2t81KMzURNGKWEMK5KI1ZGoPNzoXXAthJ_ag9O_Az5sNIRkQmO1tLSgoCpLDWHESiiFJKoiZcWF5aJMWudjtqFsbWWSF8mDiej0pnNbvfF3WjBCc1IkgbejQPC3g429bl08OAedTSYe_s1wwYVQCX39D_pwdSO1gVSA62qf8pqDqF5wSijmrMgTNX-ASquyrTOpjWqX4pMH7yYPEtPbfb-BIUa9-vL5_9nLb1P2zT12a6Hpt9E3Q58aLE5BdgRN8DEGW_81Ocf6MAV_3NCHKdDjFNBf3bn2ug</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2433244092</pqid></control><display><type>article</type><title>Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Koike, Kazushige ; Dehari, Hironari ; Ogi, Kazuhiro ; Shimizu, Shota ; Nishiyama, Koyo ; Sonoda, Tomoko ; Sasaki, Takanori ; Sasaya, Takashi ; Tsuchihashi, Kei ; Hasegawa, Tadashi ; Torigoe, Toshihiko ; Hiratsuka, Hiroyoshi ; Miyazaki, Akihiro</creator><contributor>Lee, Jung Weon</contributor><creatorcontrib>Koike, Kazushige ; Dehari, Hironari ; Ogi, Kazuhiro ; Shimizu, Shota ; Nishiyama, Koyo ; Sonoda, Tomoko ; Sasaki, Takanori ; Sasaya, Takashi ; Tsuchihashi, Kei ; Hasegawa, Tadashi ; Torigoe, Toshihiko ; Hiratsuka, Hiroyoshi ; Miyazaki, Akihiro ; Lee, Jung Weon</creatorcontrib><description>Tumor-infiltrating lymphocytes include tumor-reactive lymphocytes and regulatory T-cells. However, the prognostic value of tumor-infiltrating lymphocytes in oral squamous cell carcinoma (OSCC) remains unclear. We used immunohistochemistry to evaluate the presence of tumor-infiltrating FoxP3⺠T-cells and CTLA-4⺠cells in four distinct histological compartments (tumor parenchyma and stroma at the tumor center, and parenchyma and stroma at the invasive front) and assessed the association between the prevalence of these cells and the histopathological status of 137 patients with OSCC. Five-year overall survival, disease-specific survival, and recurrence-free survival were favorable in patients with high numbers of FoxP3⺠T-cells in the parenchyma of the invasive front. Recurrence-free survival and metastasis-free survival were decreased in patients with high numbers of CTLA-4⺠cells in the parenchyma of the invasive front. The presence of FoxP3⺠T-cells in the parenchyma of the invasive front may be a useful prognostic factor. Our results indicate that FoxP3⺠T-cells may exert site-specific anti-tumor effects but may not play an immunosuppressive role in OSCC. In addition, our results suggest that CTLA-4.sup.+ cells suppress the function of FoxP3.sup.+ T-cells and promote anti-tumor immunity in OSCC.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0237465</identifier><identifier>PMID: 32785290</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Antibodies ; Anticancer properties ; Biology and Life Sciences ; Cancer therapies ; Cell survival ; Chemotherapy ; CTLA-4 protein ; Foxp3 protein ; Genetic aspects ; Head &amp; neck cancer ; Health aspects ; Immunoglobulins ; Immunohistochemistry ; Invasiveness ; Lymphocytes ; Lymphocytes T ; Medical prognosis ; Medicine ; Medicine and Health Sciences ; Metastases ; Mouth cancer ; Oral cancer ; Oral squamous cell carcinoma ; Parenchyma ; Pathology ; Patients ; Prognosis ; Radiation therapy ; Software ; Squamous cell carcinoma ; Stroma ; Supervision ; Surgery ; Survival ; Transcription factors ; Tumor-infiltrating lymphocytes ; Tumors</subject><ispartof>PloS one, 2020-08, Vol.15 (8), p.e0237465-e0237465</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Koike et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Koike et al 2020 Koike et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-94bf09e3d9a0173578b811a640a372bfbbc63c7f515024d84ed808b42c8c9a963</citedby><cites>FETCH-LOGICAL-c669t-94bf09e3d9a0173578b811a640a372bfbbc63c7f515024d84ed808b42c8c9a963</cites><orcidid>0000-0003-3290-6205 ; 0000-0001-6880-2454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423125/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423125/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids></links><search><contributor>Lee, Jung Weon</contributor><creatorcontrib>Koike, Kazushige</creatorcontrib><creatorcontrib>Dehari, Hironari</creatorcontrib><creatorcontrib>Ogi, Kazuhiro</creatorcontrib><creatorcontrib>Shimizu, Shota</creatorcontrib><creatorcontrib>Nishiyama, Koyo</creatorcontrib><creatorcontrib>Sonoda, Tomoko</creatorcontrib><creatorcontrib>Sasaki, Takanori</creatorcontrib><creatorcontrib>Sasaya, Takashi</creatorcontrib><creatorcontrib>Tsuchihashi, Kei</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Torigoe, Toshihiko</creatorcontrib><creatorcontrib>Hiratsuka, Hiroyoshi</creatorcontrib><creatorcontrib>Miyazaki, Akihiro</creatorcontrib><title>Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma</title><title>PloS one</title><description>Tumor-infiltrating lymphocytes include tumor-reactive lymphocytes and regulatory T-cells. However, the prognostic value of tumor-infiltrating lymphocytes in oral squamous cell carcinoma (OSCC) remains unclear. We used immunohistochemistry to evaluate the presence of tumor-infiltrating FoxP3⺠T-cells and CTLA-4⺠cells in four distinct histological compartments (tumor parenchyma and stroma at the tumor center, and parenchyma and stroma at the invasive front) and assessed the association between the prevalence of these cells and the histopathological status of 137 patients with OSCC. Five-year overall survival, disease-specific survival, and recurrence-free survival were favorable in patients with high numbers of FoxP3⺠T-cells in the parenchyma of the invasive front. Recurrence-free survival and metastasis-free survival were decreased in patients with high numbers of CTLA-4⺠cells in the parenchyma of the invasive front. The presence of FoxP3⺠T-cells in the parenchyma of the invasive front may be a useful prognostic factor. Our results indicate that FoxP3⺠T-cells may exert site-specific anti-tumor effects but may not play an immunosuppressive role in OSCC. In addition, our results suggest that CTLA-4.sup.+ cells suppress the function of FoxP3.sup.+ T-cells and promote anti-tumor immunity in OSCC.</description><subject>Antibodies</subject><subject>Anticancer properties</subject><subject>Biology and Life Sciences</subject><subject>Cancer therapies</subject><subject>Cell survival</subject><subject>Chemotherapy</subject><subject>CTLA-4 protein</subject><subject>Foxp3 protein</subject><subject>Genetic aspects</subject><subject>Head &amp; neck cancer</subject><subject>Health aspects</subject><subject>Immunoglobulins</subject><subject>Immunohistochemistry</subject><subject>Invasiveness</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Metastases</subject><subject>Mouth cancer</subject><subject>Oral cancer</subject><subject>Oral squamous cell carcinoma</subject><subject>Parenchyma</subject><subject>Pathology</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Software</subject><subject>Squamous cell carcinoma</subject><subject>Stroma</subject><subject>Supervision</subject><subject>Surgery</subject><subject>Survival</subject><subject>Transcription factors</subject><subject>Tumor-infiltrating lymphocytes</subject><subject>Tumors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11rFDEUhgdRbK3-A8GAIHqxaybJ5OOmsCxWFxZatHon4Uwms5syM9kmM3X992bdUTrSC8lFwsmT9-S8nJNlL3M8z6nI39_4IXTQzHe-s3NMqGC8eJSd5oqSGSeYPr53PsmexXiDcUEl50-zE0qELIjCp9n3q-A3nY-9M-gOmsEiX6MLv7-iCLoKLa_XixlDdr8LNkbnO-Q6tIPe2a6P6Ifrt8gHaFC8HaD1Q0TGNg0yEIzrfAvPsyc1NNG-GPez7OvFh-vlp9n68uNquVjPDOeqnylW1lhZWinAuaCFkKXMc-AMAxWkrMvScGpEXeQFJqySzFYSy5IRI40CxelZ9uqou2t81KMzURNGKWEMK5KI1ZGoPNzoXXAthJ_ag9O_Az5sNIRkQmO1tLSgoCpLDWHESiiFJKoiZcWF5aJMWudjtqFsbWWSF8mDiej0pnNbvfF3WjBCc1IkgbejQPC3g429bl08OAedTSYe_s1wwYVQCX39D_pwdSO1gVSA62qf8pqDqF5wSijmrMgTNX-ASquyrTOpjWqX4pMH7yYPEtPbfb-BIUa9-vL5_9nLb1P2zT12a6Hpt9E3Q58aLE5BdgRN8DEGW_81Ocf6MAV_3NCHKdDjFNBf3bn2ug</recordid><startdate>20200812</startdate><enddate>20200812</enddate><creator>Koike, Kazushige</creator><creator>Dehari, Hironari</creator><creator>Ogi, Kazuhiro</creator><creator>Shimizu, Shota</creator><creator>Nishiyama, Koyo</creator><creator>Sonoda, Tomoko</creator><creator>Sasaki, Takanori</creator><creator>Sasaya, Takashi</creator><creator>Tsuchihashi, Kei</creator><creator>Hasegawa, Tadashi</creator><creator>Torigoe, Toshihiko</creator><creator>Hiratsuka, Hiroyoshi</creator><creator>Miyazaki, Akihiro</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3290-6205</orcidid><orcidid>https://orcid.org/0000-0001-6880-2454</orcidid></search><sort><creationdate>20200812</creationdate><title>Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma</title><author>Koike, Kazushige ; Dehari, Hironari ; Ogi, Kazuhiro ; Shimizu, Shota ; Nishiyama, Koyo ; Sonoda, Tomoko ; Sasaki, Takanori ; Sasaya, Takashi ; Tsuchihashi, Kei ; Hasegawa, Tadashi ; Torigoe, Toshihiko ; Hiratsuka, Hiroyoshi ; Miyazaki, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-94bf09e3d9a0173578b811a640a372bfbbc63c7f515024d84ed808b42c8c9a963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>Anticancer properties</topic><topic>Biology and Life Sciences</topic><topic>Cancer therapies</topic><topic>Cell survival</topic><topic>Chemotherapy</topic><topic>CTLA-4 protein</topic><topic>Foxp3 protein</topic><topic>Genetic aspects</topic><topic>Head &amp; neck cancer</topic><topic>Health aspects</topic><topic>Immunoglobulins</topic><topic>Immunohistochemistry</topic><topic>Invasiveness</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Metastases</topic><topic>Mouth cancer</topic><topic>Oral cancer</topic><topic>Oral squamous cell carcinoma</topic><topic>Parenchyma</topic><topic>Pathology</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Software</topic><topic>Squamous cell carcinoma</topic><topic>Stroma</topic><topic>Supervision</topic><topic>Surgery</topic><topic>Survival</topic><topic>Transcription factors</topic><topic>Tumor-infiltrating lymphocytes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koike, Kazushige</creatorcontrib><creatorcontrib>Dehari, Hironari</creatorcontrib><creatorcontrib>Ogi, Kazuhiro</creatorcontrib><creatorcontrib>Shimizu, Shota</creatorcontrib><creatorcontrib>Nishiyama, Koyo</creatorcontrib><creatorcontrib>Sonoda, Tomoko</creatorcontrib><creatorcontrib>Sasaki, Takanori</creatorcontrib><creatorcontrib>Sasaya, Takashi</creatorcontrib><creatorcontrib>Tsuchihashi, Kei</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Torigoe, Toshihiko</creatorcontrib><creatorcontrib>Hiratsuka, Hiroyoshi</creatorcontrib><creatorcontrib>Miyazaki, Akihiro</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koike, Kazushige</au><au>Dehari, Hironari</au><au>Ogi, Kazuhiro</au><au>Shimizu, Shota</au><au>Nishiyama, Koyo</au><au>Sonoda, Tomoko</au><au>Sasaki, Takanori</au><au>Sasaya, Takashi</au><au>Tsuchihashi, Kei</au><au>Hasegawa, Tadashi</au><au>Torigoe, Toshihiko</au><au>Hiratsuka, Hiroyoshi</au><au>Miyazaki, Akihiro</au><au>Lee, Jung Weon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma</atitle><jtitle>PloS one</jtitle><date>2020-08-12</date><risdate>2020</risdate><volume>15</volume><issue>8</issue><spage>e0237465</spage><epage>e0237465</epage><pages>e0237465-e0237465</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Tumor-infiltrating lymphocytes include tumor-reactive lymphocytes and regulatory T-cells. However, the prognostic value of tumor-infiltrating lymphocytes in oral squamous cell carcinoma (OSCC) remains unclear. We used immunohistochemistry to evaluate the presence of tumor-infiltrating FoxP3⺠T-cells and CTLA-4⺠cells in four distinct histological compartments (tumor parenchyma and stroma at the tumor center, and parenchyma and stroma at the invasive front) and assessed the association between the prevalence of these cells and the histopathological status of 137 patients with OSCC. Five-year overall survival, disease-specific survival, and recurrence-free survival were favorable in patients with high numbers of FoxP3⺠T-cells in the parenchyma of the invasive front. Recurrence-free survival and metastasis-free survival were decreased in patients with high numbers of CTLA-4⺠cells in the parenchyma of the invasive front. The presence of FoxP3⺠T-cells in the parenchyma of the invasive front may be a useful prognostic factor. Our results indicate that FoxP3⺠T-cells may exert site-specific anti-tumor effects but may not play an immunosuppressive role in OSCC. In addition, our results suggest that CTLA-4.sup.+ cells suppress the function of FoxP3.sup.+ T-cells and promote anti-tumor immunity in OSCC.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>32785290</pmid><doi>10.1371/journal.pone.0237465</doi><tpages>e0237465</tpages><orcidid>https://orcid.org/0000-0003-3290-6205</orcidid><orcidid>https://orcid.org/0000-0001-6880-2454</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-08, Vol.15 (8), p.e0237465-e0237465
issn 1932-6203
1932-6203
language eng
recordid cdi_gale_healthsolutions_A632306451
source DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Antibodies
Anticancer properties
Biology and Life Sciences
Cancer therapies
Cell survival
Chemotherapy
CTLA-4 protein
Foxp3 protein
Genetic aspects
Head & neck cancer
Health aspects
Immunoglobulins
Immunohistochemistry
Invasiveness
Lymphocytes
Lymphocytes T
Medical prognosis
Medicine
Medicine and Health Sciences
Metastases
Mouth cancer
Oral cancer
Oral squamous cell carcinoma
Parenchyma
Pathology
Patients
Prognosis
Radiation therapy
Software
Squamous cell carcinoma
Stroma
Supervision
Surgery
Survival
Transcription factors
Tumor-infiltrating lymphocytes
Tumors
title Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A13%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20value%20of%20FoxP3%20and%20CTLA-4%20expression%20in%20patients%20with%20oral%20squamous%20cell%20carcinoma&rft.jtitle=PloS%20one&rft.au=Koike,%20Kazushige&rft.date=2020-08-12&rft.volume=15&rft.issue=8&rft.spage=e0237465&rft.epage=e0237465&rft.pages=e0237465-e0237465&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0237465&rft_dat=%3Cgale_plos_%3EA632306451%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2433244092&rft_id=info:pmid/32785290&rft_galeid=A632306451&rft_doaj_id=oai_doaj_org_article_8e353a9de3c242e8ab7829d2bd67e67b&rfr_iscdi=true